Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina

Kensuke Egashira, Yousuke Katsuda, Masahiro Mohri, Takeshi Kuga, Tatuya Tagawa, Hiroaki Shimokawa, Akira Takeshita

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Objectives. The aim of this study was to investigate the basal release of nitric oxide at spastic sites in patients with variant angina. Background. We previously reported that endothelium-dependent dilator responses to acetylcholine, substance P and bradykinin are preserved at the site of coronary artery spasm. However, it is not known whether the basal release of endothelium-derived nitric oxide is altered at the spastic site. Methods. The effects of intracoronary N(G)-monomethyl-L-arginine (L-NMMA, an inhibitor of nitric oxide synthesis) at cumulative doses of 50, 100 and 200 μmol on basal coronary artery tone were investigated in eight patients with variant angina and normal coronary angiograms and in eight control subjects. The lumen diameters of large epicardial coronary arteries were assessed by quantitative coronary arteriography. Results. Coronary spasm was provoked by the intracoronary administration of acetylcholine in all patients with variant angina. L-NMMA did not alter the arterial pressure and heart rate but significantly decreased the coronary artery diameter at spastic and nonspastic sites. Constrictive responses to L-NMMA were significantly greater (p < 0.01) at the spastic site (constriction by 200 μmol, 22 ± 7%, mean ± SD) than at the nonspastic site (10 ± 7%). Constrictive responses to L-NMMA at the nonspastic site in patients with variant angina were comparable to those in the control subjects. Conclusions. These findings support the hypothesis that the basal release of nitric oxide may not be decreased at the spastic site in patients with variant angina.

Original languageEnglish
Pages (from-to)1444-1449
Number of pages6
JournalJournal of the American College of Cardiology
Volume27
Issue number6
DOIs
Publication statusPublished - May 1996

Fingerprint

Muscle Spasticity
Spasm
omega-N-Methylarginine
Nitric Oxide
Coronary Vessels
Acetylcholine
Angiography
Bradykinin
Substance P
Constriction
Endothelium
Arginine
Arterial Pressure
Heart Rate

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. / Egashira, Kensuke; Katsuda, Yousuke; Mohri, Masahiro; Kuga, Takeshi; Tagawa, Tatuya; Shimokawa, Hiroaki; Takeshita, Akira.

In: Journal of the American College of Cardiology, Vol. 27, No. 6, 05.1996, p. 1444-1449.

Research output: Contribution to journalArticle

Egashira, Kensuke ; Katsuda, Yousuke ; Mohri, Masahiro ; Kuga, Takeshi ; Tagawa, Tatuya ; Shimokawa, Hiroaki ; Takeshita, Akira. / Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. In: Journal of the American College of Cardiology. 1996 ; Vol. 27, No. 6. pp. 1444-1449.
@article{464588d4c9ad43c5b515143a2c7a4879,
title = "Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina",
abstract = "Objectives. The aim of this study was to investigate the basal release of nitric oxide at spastic sites in patients with variant angina. Background. We previously reported that endothelium-dependent dilator responses to acetylcholine, substance P and bradykinin are preserved at the site of coronary artery spasm. However, it is not known whether the basal release of endothelium-derived nitric oxide is altered at the spastic site. Methods. The effects of intracoronary N(G)-monomethyl-L-arginine (L-NMMA, an inhibitor of nitric oxide synthesis) at cumulative doses of 50, 100 and 200 μmol on basal coronary artery tone were investigated in eight patients with variant angina and normal coronary angiograms and in eight control subjects. The lumen diameters of large epicardial coronary arteries were assessed by quantitative coronary arteriography. Results. Coronary spasm was provoked by the intracoronary administration of acetylcholine in all patients with variant angina. L-NMMA did not alter the arterial pressure and heart rate but significantly decreased the coronary artery diameter at spastic and nonspastic sites. Constrictive responses to L-NMMA were significantly greater (p < 0.01) at the spastic site (constriction by 200 μmol, 22 ± 7{\%}, mean ± SD) than at the nonspastic site (10 ± 7{\%}). Constrictive responses to L-NMMA at the nonspastic site in patients with variant angina were comparable to those in the control subjects. Conclusions. These findings support the hypothesis that the basal release of nitric oxide may not be decreased at the spastic site in patients with variant angina.",
author = "Kensuke Egashira and Yousuke Katsuda and Masahiro Mohri and Takeshi Kuga and Tatuya Tagawa and Hiroaki Shimokawa and Akira Takeshita",
year = "1996",
month = "5",
doi = "10.1016/0735-1097(96)00021-6",
language = "English",
volume = "27",
pages = "1444--1449",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina

AU - Egashira, Kensuke

AU - Katsuda, Yousuke

AU - Mohri, Masahiro

AU - Kuga, Takeshi

AU - Tagawa, Tatuya

AU - Shimokawa, Hiroaki

AU - Takeshita, Akira

PY - 1996/5

Y1 - 1996/5

N2 - Objectives. The aim of this study was to investigate the basal release of nitric oxide at spastic sites in patients with variant angina. Background. We previously reported that endothelium-dependent dilator responses to acetylcholine, substance P and bradykinin are preserved at the site of coronary artery spasm. However, it is not known whether the basal release of endothelium-derived nitric oxide is altered at the spastic site. Methods. The effects of intracoronary N(G)-monomethyl-L-arginine (L-NMMA, an inhibitor of nitric oxide synthesis) at cumulative doses of 50, 100 and 200 μmol on basal coronary artery tone were investigated in eight patients with variant angina and normal coronary angiograms and in eight control subjects. The lumen diameters of large epicardial coronary arteries were assessed by quantitative coronary arteriography. Results. Coronary spasm was provoked by the intracoronary administration of acetylcholine in all patients with variant angina. L-NMMA did not alter the arterial pressure and heart rate but significantly decreased the coronary artery diameter at spastic and nonspastic sites. Constrictive responses to L-NMMA were significantly greater (p < 0.01) at the spastic site (constriction by 200 μmol, 22 ± 7%, mean ± SD) than at the nonspastic site (10 ± 7%). Constrictive responses to L-NMMA at the nonspastic site in patients with variant angina were comparable to those in the control subjects. Conclusions. These findings support the hypothesis that the basal release of nitric oxide may not be decreased at the spastic site in patients with variant angina.

AB - Objectives. The aim of this study was to investigate the basal release of nitric oxide at spastic sites in patients with variant angina. Background. We previously reported that endothelium-dependent dilator responses to acetylcholine, substance P and bradykinin are preserved at the site of coronary artery spasm. However, it is not known whether the basal release of endothelium-derived nitric oxide is altered at the spastic site. Methods. The effects of intracoronary N(G)-monomethyl-L-arginine (L-NMMA, an inhibitor of nitric oxide synthesis) at cumulative doses of 50, 100 and 200 μmol on basal coronary artery tone were investigated in eight patients with variant angina and normal coronary angiograms and in eight control subjects. The lumen diameters of large epicardial coronary arteries were assessed by quantitative coronary arteriography. Results. Coronary spasm was provoked by the intracoronary administration of acetylcholine in all patients with variant angina. L-NMMA did not alter the arterial pressure and heart rate but significantly decreased the coronary artery diameter at spastic and nonspastic sites. Constrictive responses to L-NMMA were significantly greater (p < 0.01) at the spastic site (constriction by 200 μmol, 22 ± 7%, mean ± SD) than at the nonspastic site (10 ± 7%). Constrictive responses to L-NMMA at the nonspastic site in patients with variant angina were comparable to those in the control subjects. Conclusions. These findings support the hypothesis that the basal release of nitric oxide may not be decreased at the spastic site in patients with variant angina.

UR - http://www.scopus.com/inward/record.url?scp=0029878911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029878911&partnerID=8YFLogxK

U2 - 10.1016/0735-1097(96)00021-6

DO - 10.1016/0735-1097(96)00021-6

M3 - Article

C2 - 8626956

AN - SCOPUS:0029878911

VL - 27

SP - 1444

EP - 1449

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 6

ER -